CompoAtlas

OVAFER Plus

Food supplement declared in France, declaration No 2017-3-446

OVAFER Plus (ECRH) is a food supplement declared in France. Status: retiré du marché le 26 August 2021. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
ECRH
Food business operator placing the product on the market
EVRARD OLIVIER
Status
Retiré du marché le 26 August 2021
Form
Gélule
Daily dose
1 gélule
Directions for use
1 gélule par jour avec un grand verre d'eau
Intended populations
Femme
Not recommended for (according to the manufacturer)
Enfants (moins de 12 ans), Nourrissons (moins de 1 an), Problèmes de foie, Utilisation prolongée
Objectives stated by the manufacturer (these are not authorised claims)
Mémoire, Grossesse et allaitement

Declaration 279573, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Gluconate ferreuxFer40 mg (niveau de sécurité)14 mg
Acide ptéroylmonoglutamiqueFolates (vitamine B9)1,000 µg200 µg

Additives

E460, E470b

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Tenir hors de portée des jeunes enfants Ce complément alimentaire ne se substitue pas à une alimentation équilibrée ni à un mode de vie sain.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : ECRH

Enter to analyse, Shift+Enter for a new line